FONR: FONAR Corporation Stock

by  •  • Comments Off on FONR: FONAR Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 101.42
Enterprise Value ($M) 38.84
Book Value ($M) 157.03
Book Value / Share 24.32
Price / Book 0.65
NCAV ($M) 83.23
NCAV / Share 12.89
Price / NCAV 1.22

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 9.16
Current Ratio 9.37

Balance Sheet (mrq) ($M)
Current Assets 135.83
Assets 209.63
Liabilities 52.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Renaissance Technologies Llc 4.70 -10.42
02-13 13G Vanguard Group Inc 6.05 41.55
02-13 13G/A Kayne Anderson Rudnick Investment Management Llc 9.81 0.45
02-09 13G/A Dimensional Fund Advisors Lp 6.10 0.04

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 Commission file number 0-10248 FONAR CORPORATION (Ex
2024-02-14 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended DECEMBER 31, 2023 Commission file number 0-10248 FONAR CORPORATION
2023-11-14 10-Q MFORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [ ] For the quarterly period ended SEPTEMBER 30, 2023 Commission file number 000-10248 FONAR CO
2023-09-28 10-K Securities Registered pursuant to Section 12(b) of the Act

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 3,746 32,341 11.58
2024-05-16 1,875 27,950 6.71
2024-05-15 15,711 66,667 23.57
2024-05-14 4,272 7,131 59.91
2024-05-13 2,922 26,079 11.20

(click for more detail)

Similar Companies
ECOR – electroCore, Inc. ESTA – Establishment Labs Holdings Inc.
FEMY – Femasys Inc. GCTK – GlucoTrack, Inc.
HSCS – Heart Test Laboratories, Inc.


Financial data and stock pages provided by
Fintel.io